Ori Biotech
Ori Biotech is a CGT manufacturing technology company.
Ori Biotech has raised €121M across 3 funding rounds from 7 investors, most recently a Series B round in Jan 2022. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKoribiotech.com ↗
Total raised
€121M
€121,378,572
Funding rounds
3
Investors
7
distinct backers
Active since
2020-09
latest 2022-01
Funding by year
EUR raised per yearOri Biotech — funding by year — interactive chart.
Data table
| Ori Biotech — funding by year | |
|---|---|
| 2020 | €33M |
| 2022 | €88M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-18 | Series B | €88M | Amadeus Capital Partners,Chimera Partners,Delin Ventures,Northpond Ventures,Novalis LifeSciences,Octopus Ventures+1 more | View deal → |
| 2020-10-15 | Series A | €26M | Northpond Ventures | View deal → |
| 2020-09-01 | Seed | €7.9M | — | View deal → |
Investors
7Related news
- Ori Biotech Raises Over USD100M in Series B Fundingfinsmes.com · 2022-01
- tech.eu
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData